Global /United States /Healthcare /Medical Devices /ALUR

Allurion Technologies Inc.

ALUR

• NYSE: ALUR • Delayed

0.6711USD -5.6%

As of 14 June 2026, Allurion Technologies Inc. has a market cap of $8.24M USD, ranking #42277 globally and #5437 in the United States. It ranks #3740 in the Healthcare sector, and #786 in the Medical Devices industry.

Global Rank

42277

Country Rank

5437

Sector Rank

3740

Industry Rank

786

Key Stats

Market Cap

$8.24MUSD

Enterprise Value

$85.75MUSD

Revenue (TTM)

$17.21MUSD

EBITDA (TTM)

-$38.54MUSD

Net Income (TTM)

-$32.33MUSD

EBITDA Margin

-224%

Profit Margin

-188%

PS Ratio

0.5

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

Shantanu Gaur open_in_new

Employees

137

Founded

2009

Website

allurion.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-5.6%	-43%	-33%	-58%	-68%	-42%	-72%	-100%	-100%

News

ALUR Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NYSE MIC: XNYS PRIMARY	ALUR Allurion Technologies Inc ISIN: US02008G2012 Shares Out.: Shares Outstanding: 12.279M¹ Shares Float: 10.711M² TV: TradingView: NYSE: ALUR SA: Stock Analysis: NYSE: ALUR YF: Yahoo Finance: ALUR GF: Google Finance: NYSE: ALUR NQ: NASDAQ: ALUR BA: Barron's: ALUR MS: Morningstar: XNYS: ALUR	0.6711 USD	TV: TradingView: NYSE: ALUR SA: Stock Analysis: NYSE: ALUR YF: Yahoo Finance: ALUR GF: Google Finance: NYSE: ALUR NQ: NASDAQ: ALUR BA: Barron's: ALUR MS: Morningstar: XNYS: ALUR

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Allurion Technologies Inc.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 2M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 2M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 2M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 1M%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 1M%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 1M%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 1M%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 745K%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 552K%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 441K%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 365K%	26.0	China

chevron_leftBack